Apomab

DB15022Investigational

Apomab is under investigation in clinical trial NCT00851136 (A Study of PRO95780 Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, and...

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 10B
Curator reviewed
Code names: PRO95780

Resolves to

Compound

UNII703KLX5LXZCAS1108170-71-3

Targets

O14763TNFRSF10B

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Apomab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account